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ABSTRACT 
Available data indicate that marijuana and other drugs (other than 
a1coho;l alone) constitute a traffic safety problem, and that this drug and 
driving problem may be serious. Society has responded by taking formal 
action to control the risk posed by drugs and driving. So far, research and 
countermeasure activity in this area has followed the alcohol model. 
Epiderrliological research to determine the prevalence of drugs in the 
driving population and experimental research to determine the impairing 
effects of drugs on driving has been conducted. Countermeasures to drug- 
impaired driving, primarily legal strategies to restrict drug availability and 
find and punish drug-impaired drivers, have been implemented. 
Not enough is known yet about the drug and driving problem to define 
its magnitude precisely and support countermeasure development. Research 
required to define the drug and driving problem more precisely and develop 
more effective countermeasures has been hampered by the complexity and 
variety of available drugs, and by the lack of analytic capability, funding, 
and coordination of effort. Nonetheless, a series of near-term strategies 
can be carried out by units of state and local government. Deficient state 
laws should be amended. Vigorous prosecution of impaired drivers using 
behavioral and other available evidence should continue, and nontherapeutic 
drug ulsers who choose to drive while impaired should receive license 
sanctions. The healthllegal approach should be used to find and treat 
offenders with underlying drug abuse problems. Public information and 
education efforts should focus on health care professionals and both 
therapeutic and recreational drug users. Short-term, poorly controlled, 
poorly coordinated research should be avoided; future research should focus 
on rigidly controlled, large-scale epidemiologic studies of crashed and 
noncrashed drivers, and of human performance while under drug influence. 
This paper is a guide for action by policymakers at the state and local 
level. It provides a series of strategies directed at  controlling the drug- 
crash risk-strategies that can be implemented by state and local units of 
government in the near-term future. 
DRUGS AND HIGHWAY SAFETY 
1NTRC)DUCTION 
Drug use and drug abuse are widespread in our society. Consumption 
of illicit drugs, especially marijuana, has become commonplace, particularly 
among young people. Alcohol is also frequently used in combination with 
marijurana or other drugs. Licit prescription drugs, such as tranquilizers 
and antidepressants, and such over-the-counter drugs as cold remedies, are 
also widely used, and are often consumed in combination with one another 
or wit11 alcohol. 
It is known that millions of people in the United States use drugs other 
than alcohol, that many commonly used substances have a t  least the 
potential to impair the ability to drive safely, and that many persons drive 
after consuming potentially impairing drugs. This suggests that drugs, both 
licit and illicit, present the potential for causing traffic crashes, and that 
society should take action to control the drug-crash problem. 
What is not yet known is the precise extent to which drug use 
contributes to the occurrence of traffic crashes. In spite of an ever- 
expanding body of literature on drugs and driving (e.g., Joscelyn and 
Donelson 1979; Joscelyn and Maickel 1977b), studies conducted to  
determine the prevalence of drugs among drivers, and experiments to 
discover the potential of drugs to impair driving skills, there are still no 
definitive studies linking drug use and traffic crashes, The available 
evidence does suggest that drugs other than alcohol can impair driving 
skills and may increase the likelihood of traffic crashes. Research and 
police investigations have documented drug involvement in specific traf fie 
crashes and have led to the conclusion that drug-impaired driving causes 
traffic crashes. Drivers are regularly, though infrequently, arrested and 
prosecuted for drug-impaired driving. While the available evidence lends 
credence to the belief that a "drug and drivingu problem exists, its 
magnitude is still unknown. Until the problem can be better quantified it 
cannot be labeled a priority highway safety concern. 
Figure 1 presents a structural representation of society's efforts to solve 
the problem of drugs and highway safety. The most general description of 
the relationship between drugs other than alcohol and traffic crashes is 
that it is highly complex and at best indirect. Equally complex research is 
required to define the relationship between drugs and crashes to  permit 
development of specific strategies to manage the drug-crash risk. 
To date, society's approach to drugs and driving parallels the alcohol- 
crash experience. Public concern about drugs and driving is part of a 
more general concern about the widespread use--and abuse--of drugs. 
Countermeasures directed at  the drug-crash problem correspond to those 
directed at  the alcohol-crash problem: restricting availability; punishing 
those who drive while under the influence; and educating the public about 
the danger of drugs and about society's efforts to curb drug-impaired 
driving. 
Unlike alcohol, a quantitative relationship between drug concentrations 
in the body and impairment of driving ability has not yet been established 
and, in some cases, never will be. This means that alternative means of 
enforcing laws against drug-impaired driving and prosecuting suspected 
offenders should be considered. Strategies that do not rely solely on law 
enforcement should also be applied to the drug and driving problem. 
A series of approaches can and should be used by policymakers at  the 
state and local level in the near-term future to deal with drug-impaired 
driving. This paper describes several of those strategies. It also sketches 
in broad terms the dimensions of the drug and driving problem; the current 
s t a t e  of knowledge about drugs and driving; major areas in which 
knowledge is lacking and research is needed; and what is being-and can 
be-done about drugs and driving, based on current knowledge. 
DEFINING THE DRUG A N D  DRIVING PROBLEM 
Drugs and traffic safety remains a rather data-poor field. Reliable 
figures about the number of drug-related traffic crashes and the magnitude 
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of these crash-related losses are not available. Statistical studies, most of 
them possessing methodological and operational problems, indicate that 
about 1 4  to 26 percent of drivers killed in traffic crashes had one or more 
drugs other than alcohol in their body, Analyses of fatal  crashes, 
conducted by the Midwest Research Institute (Blackburn and Woodhouse 
1977; Glauz and Blackburn 1975)  showed that 14 to 24 percent of the 
specimens taken from fatally injured drivers contained one or more drugs, 
chiefly the cannabinoids. Teale and associates (1977) found that nine 
percent of all fatally injured drivers tested positive for marijuana. 
Sterling-Smith and Graham (1976) found that 16 percent of the at-fault 
drivers involved in fatal  crashes tested positive for that  substance; 
however, that  study has been severely criticized for methodological 
imperfection. Cimbura and associates (1980) a t  the Traffic Injury Research 
Foundation of Ontario reported that among fatally injured drivers in 
Ontario, 1 2  percent had drugs alone in their body, and another 1 4  percent 
had alcohol and other drugs. Of the drugs found in drivers1 blood and 
urine, cannabinoids (marijuana) were the most common, followed by 
salicylate (aspirin), diazepam (an antidepressant), and codeine. Sixty-nine 
percent of those tested positive for cannabinoids also had alcohol in their 
body. The Canadian data should be read cautiously, however, since drugs 
were identified from urine specimens that contained drug traces after their 
impairing effects had dissipated, Blood specimens gathered in that study 
indicated that only one in four marijuana-positive cases established recent 
use-and even this evidence does not necessarily establish impairment. The 
Ontaleio study also classified as ttdrugsfl substances, such as salicylate, that 
are not impairing unless taken in grossly excessive amounts. 
Treat and associates, reporting the results of their clinical study of 
traffic crashes in Monroe County, Indiana, estimated that impairment by 
drugs other than alcohol was at  least a possible cause of four percent of 
all crashes-an estimate that is believed by the principal investigator to be 
conservative for crashes in general and especially with respect to fatal and 
serious crashes (Treat 1980). Even so, a four percent involvement rate 
translates, in round figures, to an annual total of 2,000 fatalities, 80,000 
serious injuries, nearly three-quarters of a million traffic crashes, and a 
total cost to the public approaching one and one-half billion dollars. These 
estimates are based on figures compiled by the National Safety Council 
(1980). 
THE ALCOHOL AND HIGHWAY SAFETY EXPERIENCE: HOW 
RELEVANT TO DRUGS AND DRIVING? 
The Alcohol-Highway Safety Experience 
Alcohol was widely used long before the invention of the automobile. 
Alcohol-impaired driving was quickly identified as a potential cause of 
traffic crashes, By the 1930s, concern over the alcohol-crash risk rose to 
the point where scientific study of the problem was advocated. Two 
approaches to defining the alcohol-crash problem emerged: epidemiology, 
dealing with the prevalence, distribution, and control of alcohol-related 
traffic crashes; and experimentation, controlled studies that measured the 
effects of alcohol on human performance, especially on skills believed 
related to safe driving. Epidemiologic and experimental research was 
suppor'ted by a third approach, detection and quantitation of alcohol in 
body fluids. A proven and useful variable, blood alcohol concentration 
(BAC), was developed. BAC could be obtained with little difficulty by 
drawing a small specimen of one of the driver's body fluids and analyzing 
it ,  using any of a variety of chemical analysis techniques. Using BAC 
levels, researchers proceeded to establish that higher BACs were more 
freque!ntly involved among crashed drivers (epidemiological approach) and 
that driving performance tends to  d e t e r i o r a t e  as BAC increases  
(experimental approach). 
Toclay the nature and magnitude of the alcohol-crash problem has been 
estimated but not fully defined. About one-half of all fatally injured 
drivers, ten percent of drivers involved in personal-injury crashes, and five 
percent of those involved in property-damage crashes have BACs in excess 
of the generally accepted legal limit of . l o% w/v (Jones and Joscelyn 
1978). As evidence linking alcohol and traffic crashes mounted, society 
developed and implemented countermeasures to reduce the incidence of 
alcohol-impaired driving. The primary countermeasure approaches were 
legal: laws were passed prohibiting driving while under the influence (DUI) 
and specifying the legal effect of chemical test evidence. Implied-consent 
laws were enacted to facilitate the chemical testing process and make it 
safer ,  more reliable, and acceptable to the public. Laws provided for 
criminal and administrative (driver-licensing) penalties for those convicted 
of DUI and, more recently, courts have established treatment programs for 
DUI offenders with drinking problems. At the same time laws were passed 
to deal with alcohol-impaired driving, public information and education 
efforts were undertaken. The goal of these programs was to establish a 
public knowledge base about alcohol and highway safety that would 
discourage impaired persons from driving and create public support for 
action against impaired drivers. 
Response t o  t h e  Drug and Driving Problem 
For more than half a century, state laws have prohibited driving while 
under the influence of narcotic drugs. However, prior to 1960, there was 
little public interest in possible highway safety problems due to drugs other 
than alcohol. Since then several factors-the continued development and 
widespread use of new psychoactive drugs; increased nonmedical use of 
drugs (including misuse of therapeutic substances and illicit use of 
nontherapeutic substances); and the combined use of alcohol and other 
drugs (sometimes termed tlpolydrug useu)-have increased the level of public 
concern over drugs and highway safety (Joscelyn et al. 1980). 
The primary means of addressing the drug and driving problem, as in 
the case of alcohol, is the legal approach. Drug-impaired driving is 
prohibited by law, and the availability of many drugs is severely restricted. 
Extensive public information llcampaigns" have stressed the dangers of drug 
use in general. However, with respect to defining and better addressing 
the problem of drugs and highway safety, the state of knowledge about 
drugs and driving is still, as one researcher described it, in a prolonged 
state of infancy. The field contains few full-time practitioners, funding is 
scarce,, research is fragmentary and widely scattered, and epidemiological 
studies are lacking. This stands in sharp contrast to the alcohol-crash 
field, where research is well-established and coordinated. 
Still, the alcohol experience is the pattern followed by drug and driving 
research. It provides perspective but, for a number of reasons, it is not 
fully applicable. Alcohol has different properties than other drugs. It is a 
sinqle chemical entity with a simple molecular structure; other drugs 
number into the thousands, vary in structure, and are usuallv complex 
chemic!als. Alcohol is a qeneral depressant, while other drugs provide 
stimulation, hallucination, analgesia, depression, and other effects. Alcohol 
is rapidly absorbed and metabolized by the human body, while other drugs 
vary greatly in the rate of absorption, metabolism, and excretion. Other 
drugs are rarely secreted in the breath in significant amounts, and traces 
of drugs can remain in the body long after their effects have ceased. 
Alcohol is a l'recreationalu drug, while other drugs are used therapeutically 
as well as recreationally, and much recreational drug use is illicit. 
Alcohol is widely available and its moderate use is tolerated; most 
therapeutic substances are tightly controlled and distributed through the 
health--care system, and the use of most nontherapeutic substances is 
prohibited. Most important, though, is that alcohol can be detected and 
quantitated in the body, while most other drugs cannot. There are a t  
present no objective measures of impairment by substances other than 
alcohol, and none are likely to be developed in the near future. 
Without objective impairment standards for drugs other than alcohol, 
progress in meeting many of the data needs in regard to dealinq with the 
drug and driving problem is likely to be slow. Major data needs include: 
Valid and reliable behavioral methods to measure the  
effects of drugs on skills related to driving, and to detect 
drug-impaired drivers; 
D Sensitive analytic methods to determine the presence of and 
measure the amount of drugs in body fluids; and 
D Methods to support specific countermeasures aimed at the 
drug and driving problem (Joscelyn et al. 1980). 
THE STATE OF DRUG AND DRIVING RESEARCH 
Today society is aware that drugs other than alcohol are potential 
contributing factors in traffic crashes, just as i t  became aware of the 
existence of the potential alcohol-crash problem early in this century. The 
drug and driving problem remains ill-defined, though, and this in turn 
constrains the development of countermeasures in this area, 
It has been said that the present state of knowledge regarding drugs 
and highway safety parallels that which existed about alcohol half a 
century ago. In the alcohol model, which drug and driving research has 
substant ial ly  followed, research has been both epidemiological and 
experimental, and has been supported by detection and quantitation 
procedures relating mainly to blood alcohol concentrations. Figure 2 
depicts drug and driving research as a process that advances the state of 
knowledge toward problem definition. Each step of the process requires 
progressively more rigorous study, using epidemiological and experiment a1 
methods in concert. Initial exploratory studies narrow the focus for later 
efforts, for example, by narrowing the range of drugs of interest from the 
thousands of available substances to a more limited set. While the 
overinvolvement of specific drugs in traffic crashes is measured, the 
properties of specific drugs associated with traffic crashes will be 
identified. As the drug and driving problem becomes more clearly defined, 
countermeasure approaches--which currently parallel those directed at 
alcohol-will become better developed. 
Epidemiological Research 
Epidemiologic research is aimed at determining, first, whether the use 
of drugs other than alcohol alone increases the likelihood of traffic 
crashes; and second, what behavioral errors by drivers are associated with 
their use of drugs. The overall aim of epidemiological research is t o  
ident ify spec i f ic  t a r g e t s ,  namely drugs and classes of users, for 
countermeasure programs. 
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Findings. Epidemiologic studies of drug use among driving populations 
have used three basic approaches to gathering data: questioning drivers 
about their use of drugs and their drug-impaired driving; examining the 
driving records of known drug users; and analyzing drivers' body fluids for 
drug presence and concentrations. 
The general findings of the epidemiological studies to date indicate the 
magnitude of a drug and driving problem in the United States, but the 
available data do not reliably define the problem. 
Other than alcohol, the substance of most interest as a potential cause 
of traffic crashes is marijuana. The use of marijuana among the driving 
population, and marijuana presence in the body fluids of crashed and 
impaired (arrested) drivers, have been studied in various localities. No 
nationwide study of marijuana and driving--or any other drug other than 
alcohol-has been conducted. Findings of limited epidemiological studies of 
a marijuana presence have been limited until recently by the lack of 
technology for detecting marijuana in body fluid specimens. Available data 
suggest that both the fatally injured and impaired driving populations 
contain marijuana users, and that marijuana is frequently consumed in 
combination with alcohol or other drugs (see, e.g., Cimbura e t  al. 1980; 
Reeve 1979). One weakness of the findings regarding marijuana is that the 
presence of cannabinoids in a driver's urine indicates only prior use, and 
not necessarily impairment by the substance, Even finding marijuana 
constituents in the blood does not indicate impairment a t  the time the 
substance was withdrawn. To date, the data are not conclusive or 
complete, and they neither support nor refute arguments that marijuana is 
or should be a significant highway safety concern, 
Measurement of the concentrations of benzodiazepines (antianxiety 
agents) is now possible with more sensitive analytical techniques now 
available. Studies of s u s ~ e c t e d  drug-impaired drivers in California 
(Lundberg, White, and Hoffman 1979) and in Texas (Garriott et al. 1977) 
indicated that antianxiety agents were present in roughly 20 to 30 percent 
of the drivers arrested for drug-impaired driving, and that polydrug use 
involving these substances was common. Bo and associates ( 1 9 7  51,  
compaliing limited samples of crashed and noncrashed drivers, found 
diazepam ( ~ a l i u m m )  overrepresented in  the crashed group. Other  
sedative-hypnotics have been detected in the body fluids of suspected 
impaired drivers, but there are no studies comparing the prevalence of 
these (drugs in crashed and noncrashed drivers. Little data are yet 
availalble regarding other controlled substances, because most of these 
drugs are present in the blood at extremely small quantities and because 
past ~~nalyses  have used urine specimens, which contain traces of drugs 
that remain in the body long after their impairing effects have ceased. 
Methodological Problems. Each of the primary epidemiological study 
methods has weaknesses that limits the value of data collected using that 
methold. Questionnaire studies are limited in general by the unknown 
reliability of self-reported data. Subjects are likely to understate their 
drug use and impairment out of fear of legal reprisals, and their responses 
are not subject to verification by chemical tests. In addition, many 
questionnaire studies are based on samples of convenience and therefore 
cannot be used to support inferences about the driving population i n  
general. Examination of driving records is even more indirect and even 
less reliable than using questionnaires. Many traffic record systems are 
not of good quality. Even when well maintained, driving records cannot 
specify which crashes or traffic violations occurred while the subject was 
under the  influence of drugs. Moreover, the same factor may be 
responsible for the traffic incidents that appear on the subject's record and 
for the subject's use of drugs in the first place. The most direct 
approach, obtaining body fluid specimens and analyzing them for drugs, is 
expensiwe and time-consuming, and many analytic instruments now in use 
are not sufficiently sensitive to find all the drugs of interest. Many police 
departments, medical examiners, and coroners, as well as private and 
university-based researchers, have analyzed specimens drawn from deceased 
drivers, and some epidemiological data have been obtained in that manner, 
With respect to injured, cited, and other living drivers, research on drug 
preval.ence becomes more problematical. Difficulties include the 
unwillingness of hospitals to  cooperate in and support epidemiological 
studies, drivers' refusal to qive the i r  informed consent  t o  the i r  
participation, and constraints on federal agencies that prevent them from 
conducting or sponsoring roadside studies of drug use by drivers. 
A number of other problems are present in epidemiological research. 
First, since most drugs are used far less frequently than alcohol, and since 
t ra f f ic  crashes are comparatively rare events, traditional epidemiologic 
research may require extremely large sample sizes and entail prohibitive 
costs. Second, interpreting the findings of druq analyses is much more 
difficult and much less straightforward than is the case with alcohol. For 
example, in tfpolydrugll cases the combined used of drugs may be inferred 
as a cause of traffic crashes; however, no single substance may be present 
in a concentration indicative of impairment. Another illustration is the 
possibility of drug ttunderdoses," A driver who has taken a therapeutic 
drug in smaller amounts than necessary to relieve a medical condition may 
be too impaired to drive, but the impairment is caused by a deficiency of, 
and not an excess of, the therapeutic drug found in the driver's body. 
Finally, existing analytic techniques are not sensitive enough, in many 
cases, to rule out the role of certain drugs, either because they were not 
looked for, or because existing technology cannot detect such small but 
impairing quantities. 
Experimental Research 
Experimental research is aimed at determininq, first, whether drugs 
other than alcohol impair driving performance; second, whether combined 
drug or combined alcohol and o ther  drug effects impair driving 
performance; and third, how measures of drug use (such as quantity 
consumed, frequency of use, or body arug concentration) relate to measures 
of driving performance. 
Findings. Research to date has been voluminous but has not fully 
answered the basic questions about the effect of drugs other than alcohol 
on driving performance. Evidence from laboratory tests indicates that 
marijuana at  certain dosages, used alone or in combination with alcohol or 
other drugs, impairs skills and behaviors related to safe driving. Less 
numerous studies involving actual vehicle handling generally support the 
implication that marijuana--especially when taken in large doses--can 
increase the likelihood of a traffic crash. Studies of benzodiazepines 
(antianxiety agents) have differed widely in experimental design and 
procedures, which has produced diverse findings about the effects of these 
substances on psychomotor skills. There are indications, though, that 
benzodiazepines can further reduce performance already impaired by 
alcoho:l, and that their chronic or repeated use may produce cumulative 
and residual (tfhangovertf) effects. Other sedative and hypnotic agents 
are similar to alcohol in their potential to depress the central nervous 
system; large doses or combined use with alcohol can impair driving skills. 
The effects of other central nervous system stimulants (including the 
amphetamines and cocaine) on driving are not clearly established, although 
these substances may have an indirect effect, namely withdrawal. Sudden 
loss of' consciousness may occur once the stimulant effects of these drugs 
subside!; this phenomenon is relatively well known among truck drivers who 
use "pep pills." Few studies have been conducted for other controlled 
substances, although one substance, phenycyclidine (PCP or "angel dustv), 
is known to produce severe impairment of nervous and cardiovascular skills 
and has been implicated in a number of accidental deaths, including fatal 
traffic crashes. 
Method,ological Problems. Our review of the research to date 
identified three general methodological weaknesses in most experimental 
studies. First, many routinely conducted experiments have limited validity 
or cannot be related to everyday driving; moreover, experiments purporting 
to measure like behaviors often cannot be compared to one another, 
because their procedures differ so greatly. Second, many experiments 
contain weaknesses in design (such as selection of unrepresentative 
subjects) that call their results into question; these weaknesses are 
aggravated by inadequate reporting of the researcherst methods for 
measuring behavior and analyzing data, and the lack of such critical 
information as concentrations of active agents that the subjects received. 
Third, drugs are often administered to subjects in quantities and at 
intervals that do not reflect common drug use patterns among the user 
population; moreover, as already stated, research subjects often do not 
reflect the user population (Joscelyn et al. 1980). 
Reasons for the disarray of the experimental research include the sheer 
number and diversity of drugs and their effects; the wide range of methods 
used by researchers to  measure behavior; and the numerous variables 
pertaining to drug, subject, and experimental design. While no experiment 
in drugs and driving can control for all of the relevant variables, there is 
a disturbing pattern of discontinuity and lack of coordination across the 
drug and driving field. Results are equivocal about the potential traffic 
crash risks posed by drugs other than alcohol. 
Nevertheless, in spite of the weaknesses of experimental research, 
existing findings indicate that the use of such frequently studied drugs as 
marijuana and diazepam ( ~ a l i u d ) ,  especially in combination with alcohol, 
may increase the likelihood of traffic crashes and, more generally, that 
drugs other than alcohol have the potential to increase the risk of a 
traffic crash. 
Detection and Quantitation of Drugs 
Development of an equivalent to blood alcohol concentration for a t  
leas t  the most widely used drugs other than alcohol would support 
epidemiological and experimental research that will better define the drug 
and driving problem, So far no such equivalent has been developed for any 
substance. This does not mean that drugs present in the human body 
cannot be detected, nor does it mean that drug concentrations cannot be 
determined. However, unlike chemical testing for alcohol, which is 
relatively simple and straightforward, analysis of other drugs is hampered 
by the variety and complexity of available substances, The testing of 
blood--the only substance from which meaningful analytic results can be 
obtained (Joscelyn et al. 1979)--is complex, and most drugs can affect 
human performance when present in the blood in minute quantities. As a 
consequence, more sophisticated and costlier analytic techniques are needed 
to analyze for drug presence and concentration. 
Most methods of analyzing body fluid specimens for drugs other than 
alcoholl involve four steps (see Figure 3). The first step is separation of 
the drug from the blood to isolate it as much as possible. Usually the 
drug to be analyzed is still bound to other chemicals at this point, so 
isolati.on of the drug is necessary to gather the drug of interest by itself 
for identification. Once the drug is isolated, chemical or electronic 
detection methods are used to make a qualitative identification of what 
drug is present. The task of separating, isolating, and identifying the drug 
is complicated in most cases because the analyst does not know in advance 
what drugs are present or expected in a particular specimen. (This 
problem does not exist when analyzing for alcohol.) Unlike alcohol, other 
drugs number into the thousands, which means that the analyst is forced to 
concentrate on a limited set  of "drugs of interestw--substances whose 
presence reasonably can be expected. Drugs not expected to appear in the 
specimen will go unnoticed. Moreover, limitations on cost, time, and size 
of specimens limit the range of substances for which analyses can be 
performed. Once a drug or drugs has been identified, a quan t i t a t ive  
measurement of drug concentration is performed. From the size of the 
specimen, and the proportim of the specimen that actually underwent 
quantitative measurement (known quantities of chemicals, called "internal 
standal?dsf1 are added for this reason), the drug concentration in the body 
can be determined. 
The s ta te  of the a r t  in analytical methods for drug detection and 
quantitation has advanced greatly since about 1975 (e.g., Joscelyn e t  al. 
1979; Joscelyn and Maickel 1977a; Sunshine 1975). Recent developments 
include! gas chrornotography-mass spectroscopy, which separates drugs and 
records the "fingerprint1' or identifying characteristcs of each; and 
immunloassay, a sensitive, selective, and rapid procedure using radioactive 
substances, that can process large numbers of specimens. 
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Methodological Problems. Despite recent advances, the major 
problems in drug detection and quantitation remain the high cost and labor 
intensivity of state-of-the-art analytic techniques and the continued need 
to develop more sensitive analytical capability. Moreover, no matter how 
advanced detection and quantitation procedures may become, i t  is 
necessisry in the first place to obtain specimens from drivers. Deceased 
drivers are currently the best source of specimens, because police officers 
or death investigators i n  some jurisdictions routinelv draw them for 
postmortem analysis, and because informed-consent and other human- 
subjects issues do not arise. Still, laws inhibit postmortem examinations in 
some jjurisdictions; police departments, even when allowed by law, are 
r e l ~ c t ~ a n t  to draw specimens; many police officers are unaware of the 
value iof specimens; and time and funds are not always available for 
government a1 agencies to gather and analyze specimens (Donelson et al. 
1980). Even when analysis occurs, not all drugs of interest are studied, 
and misny common analytic procedures fail to find drugs that are present 
at  less than toxic but nonetheless impairing levels. Because a variety of 
laboratories conduct drug analyses, and because procedures and standards 
are not uniform, comparison among studies is generally not feasible. 
Ongoing and Planned Activity 
Recent ly we directly contacted a sample of public and private 
organiz~ations involved in drug-related research to determine what activity 
was either underway or planned. In the realm of epidemiologic research, 
two approaches-obtaining self-reported data on drug use and drug-impaired 
driving,, and collecting driverst body fluids and analyzing them for drups- 
are emphasized. General objectives of research include developing methods 
of studying drug use patterns among drivers, determining the extent of 
drug use among drivers, and obtaining data kept by police departments and 
other agencies that indicate the prevalence of drugs among drivers. Local 
and state efforts to detect and measure drugs in driverst body fluids are 
underway in various locations, but differences among studies, as well as 
biases in selecting drivers, may limit the value of these studiest findings. 
Currently no nationwide epidemiological study of drugs o the r  than  
alcohol is underway or even planned. More importantly, neither ongoing 
nor planned activity includes studies that compare drug prevalence among 
crashed and noncrashed drivers. Until such studies are funded and carried 
out, the state of knowledge about drugs and driving will not advance. 
Current and planned experimental research is systematically attempting 
to correlate drug concentrations in the body with the impairment of 
driving-related skills. Although this study will not soon lead to the 
establishment of BAC-equivalents for drugs other than alcohol, i t  will 
identify methodological problems involved in developing them, and will give 
some indication of the variability among research subjects. Experiments 
underway a t  two universities are  aimed a t  examining the effects of 
marijuana use on vehicle handling. Other research on drug effects and 
into human performance in general, while not directly related to drugs and 
highway safety, may produce findings that will further define the impairing 
e f f e c t s  of drugs on dr iving-related skills ,  In general,  current 
experimentation has the potential to  remedy the chief weaknesses of 
existing experimental data, especially the questionable validity of many 
laboratory and other tests. 
The s t a t e  of the a r t  in detection and quantitation methods has 
advanced greatly in recent years, but many analytic procedures are so 
costly and labor-intensive that their widespread adoption has lagged. 
Today police agencies, death investigators, and researchers are increasingly 
analyzing body fluid specimens for drugs other than alcohol, and are 
handling a widening range of substances. Curpent and planned research 
includes developing methods of analyzing saliva or even breath specimens 
for drugs, developing a reliable and widely available technique for  
marijuana analysis, and developing portable instruments that will permit 
roadside testing in connection with law enforcement. Also underway are 
programs to improve laboratoriesf capabilities to analyze for drugs, and to 
improve quality control within laboratories. 
Presently the major obstacle to drug and driving research in relation to 
alcohol and driving research is the lack of data that can support the 
establilshment of BAC-equivalents for drugs other than alcohol. Without 
such equivalents, i t  is difficult to determine with precision whether a 
driver--crashed, arrested, or a t  risk--is incapable of driving safely by 
reason of drug consumption. It is unlikely that BAC-equivalents will be 
developed in the near future, and it is possible that they may never exist 
for sorne drugs. In any event, some reliable procedure for measuring other 
drug impairment must be developed and put into use. 
COUN'TERMEASURES TO THE DRUGS AND DRIVING PROBLEM 
In dealing with the drug and traffic safety risk, society has a t  i ts  
disposal a number of countermeasure approaches for controlling that risk. 
These include the legal approach, the health approach, the technological 
approach, and the public information and education (PI&E) approach. 
Often, two or more approaches are applied in concert, such as the 
llhealth/legalll approach to alcohol and traffic safety. When systematic and 
combined use is made of several approaches, a llsystems approachv is said 
to be used. 
Legal Countermeasures 
As in the case  of alcohol-impaired driving, society's principal 
counterlmeasure approach to the problem of drugs and driving is legal. 
Legal countermeasures to drug-impaired driving include two broad 
strategies: the indirect approach of restricting the availability of 
substances tha t  can impair driving performance (and cause other 
undesirable public health consequences); and the direct approach of using 
punishment to discourage drivers from operating vehicles while under the 
influence of drugs. 
Drug Control Laws. Both federal and s ta te  laws restrict the 
manufacture, distribution, possession, and use of substances that can be 
abused. These drug-control laws seek to reduce problems stemming from 
improper drug use by forbidding persons likely to abuse them from having 
access to them, This approach is found, though to a leser extent, with 
respect to alcohol: a limited number of licensed distributors are permitted 
to sell alcoholic beverages, and certain classes of persons (chiefly minors) 
are forbidden access to them. In the case of drugs other than alcohol, 
access to therapeutic drugs capable of being abused is generally restricted 
to the health-care system, and access to nontherapeutic drugs of abuse is 
essentially forbidden. The most important drug-control laws are the 
controlled-substances acts. The federal controlled-substances law, called 
The Comprehensive Drug Abuse Prevention and Control Act of 1970, limits 
the manufacture of designated drugs, regulates their distribution, supervises 
both, and provides punishments for violators. State law consists not only 
of controlled-substances acts (which are generally patterned after federal 
law) but also laws and regulations that govern the practice of medicine 
and pharmacy. These professional regulations in effect govern the 
distribution and use of drugs, since many substances other than alcohol are 
primarily distributed through the health-care system. 
Driver-Control Laws. It is common knowledge that drug-control laws 
do not prevent drug abuse, nor do they prevent unauthorized persons from 
possessing or using drugs of abuse. It is also well known that many freely 
available drugs have the potential to impair driving ability; packages 
containing prescription and over-the-counter remedies often contain 
warnings against driving after using them. Nevertheless, in spite of these 
a t t e m p t s  a t  control ,  many persons do drive after using impairing 
substances, and these persons represent a traffic safety hazard. 
Thus society has reacted to  the presence of impairing drugs in an 
automobile-oriented society by enacting legislation aimed at  discour aging, 
or deterring, drug-impaired driving through punishment and the threat of 
punishment. For about half a century, state vehicle codes have forbidden 
driving while under the influence of drugs (DUID) and have made such 
conduct punishable by criminal penalties (fines and confinement to jail) and 
administrative sanctions (loss or restriction of driving privileges), Al l  
states today prohibit drug-impaired driving. Still, drug-impaired driving has 
attracted little attention in comparison to drunk driving; moreover, prior to 
about 1960, the level of public concern over drugs and driving was low. 
Enforcement of DUID laws parsllels that of drunk driving laws, although 
a much lower priority is placed on the drug-impaired offender. Police 
training for DUID law enforcement is based on the same observations of 
driving behavior as drunk driving. Once a driver is stopped, the decision 
to arrest for DUID is usually based on the driver's possession of drugs 
other than alcohol, visible impairment with no odor of alcohol, or 
admission of drug use. In some cases, an arrest is originally made for 
drunk driving and, following chemical tests that indicate the driver had not 
been drinking, the charge is amended to DUID. Arrests for DUID are 
comparatively rare among impaired-driving arrests. Statistics indicate that 
about one drug-impaired driving arrest is made for every one hundred 
drunk driving arrests. Compared to drunk driving, DUID conviction rates 
are lower and plea bargaining is more frequent because of the greater 
difficulty of proving guilt in DUID cases. Sanctions for DUID tend to be 
similalr in severity to, or somewhat more severe than, those imposed on 
convicted drunk drivers. Drug-impaired drivers, like alcohol-impaired 
drivers, are also sanctioned by having administrative action taken against 
them by the driver-licensing authority. Mandatory license suspensions for 
those convicted of driving while under the influence of drugs or alcohol 
are commonly provided for by state law, and courts often impose license 
suspensions or restrictions as part of the sanctions for impaired driving. 
On occasion, drivers with drug or alcohol problems are referred to medical 
review panels within driver-licensing authorities, and sometimes their 
retaining driving privileges is conditioned on obtaining treatment or 
abstaining from impairing substances (Joscelyn e t  al. 1980). 
Enforcement of D U I D  laws, although procedurally similar to the  
enforcement of drunk-driving laws, is made more difficult by several 
factors. First of all, unlike BAC measurements for alcohol influence, 
there are no quantitative measurements equating other drug concentration 
with impairment of driving performance. Sometimes it is possible to show 
that the drug concentration in a given driver's body greatly exceeded the 
therapeutic concentration or even approached a toxic level, or to introduce 
expert testimony that a driver had used an impairing quantity of a 
nontherapeutic substance such as marijuana. Second, because blood is the 
only body fluid that can yield meaningful findings regarding drug presence 
and concentration, chemical testing for drugs other than alcohol is much 
more difficult to carry out than testing for alcohol; the latter is commonly 
done using inexpensive, widely available, and sometimes portable breath- 
testing equipment. Third, since drugs other than alcohol are often used in 
combination with one another or in combination with alcohol, both physical 
and chemical evidence can fail to indicate what specific substance resulted 
in driving impairment. All of these problems hinder the proof of guilt a t  
a DUID trial. 
Problems of Legislation Related to  DUID. In most states the 
practical difficulties of proving guilt of DUID are compounded by 
provisions of state law that further hamper the gathering of evidence for 
use in a DUID trial. Although every state has a law prohibiting DUID, 
and has a so-called vimplied-consentv law that facilitates and governs the 
use of chemical test evidence, there is considerable difference among state 
provisions. The model driver-control laws related to DUID are found in 
Sections 6-205.1, 11-902, and 11-902.1 of the Uniform Vehicle Code (UVC), 
prepared by the National Committee on Uniform Traffic Laws and 
Ordinances (1979). A small number of states, such as Georgia, have 
adopted s tate  laws similar to those of the Code, but most statesf laws 
have one or more substantial departures from the model provisions. 
Typical weaknesses of state laws include: 
Narrow definition of "drug." The Uniform Vehicle Code 
prohibits driving while under the influence of "any drugrf but 
many state laws use definitions such as Ifcontrolled substancef1 
or "narcotic drug," or exclude legal therapeutic drugs from the 
definition. Such legislation is underinclusive with respect to 
impaired drivers whose drug influence--legal or not--still 
presents a safety hazard. 
a Restrictions on testing. The Code allows for blood, 
breath, or urine tests, and allows the arresting officer to 
choose what test is to be given. Many state laws, however, 
either limit the officer to a breath test, or allow the driver to 
choose from among available tests and thus avoid a blood 
analysis. Such legislation permits a driver who is under the 
inf luence  of substances other than alcohol to avoid the 
discovery of evidence of drug influence. 
Failure to cover npolydrugn use. The Code's DUID 
provisions prohibit driving while under the influence of any 
combination of impairing substances. Many state laws fail to 
deal with combined influence (alcohol and other drugs; other 
drugs combined) and present possible difficulties in prosecution. 
Lack of power to analyze specimens for other drugs, 
Many states? implied-consent laws apply to alcohol only and do 
not allow for the introduction of other drug analyses into 
evidence a t  a trial. The Uniform Vehicle Code allows the 
introduction of evidence of alcohol, other drug, or combined 
concentrations in trials. 
Weaknesses of existing state laws have contributed to prosecutors? problems 
in handling DUID cases. Many prosecutors are of the opinion that the 
chances of obtaining a conviction in a DUID trial are poor, especially when 
the only evidence available consists of the officer's testimony about the 
driver's physical condition and driving performance, with no chemical 
evidence pointing to drug consumption or influence, Plea bargains to less 
serious charges such as reckless or careless driving, or dismissals of DUID 
charges, are common outcomes of DUID arrests. 
Ourb companion volume, Alcohol, Drugs, and Traffic Law (Joscelyn and 
Ruschrnann 1981), discusses in more detail the deficiencies of existing 
legislaation and makes recommendations for legislative reform. 
Health Countermeasures 
Health countermeasures involve the health care system either by 
changing the manner in which it delivers drugs to patients or delivers 
information related to drugs and their effects; or by enlisting their help in 
treating and rehabilitating those who have drug-related problems. 
One well-known, direct countermeasure directed a t  drug-impaired 
driving uses the legal system to "find" impaired drivers who are dependent 
on aloohol or other drugs and refer them to appropriate treatment 
programs. Referrals are frequently made by courts or driver-licensing 
authorities in connection with the sanctioning process, typically as a 
condition of the offender's re ta in ing  driving privileges. Heal th 
countermeasures operating in concert with legal countermeasures are 
sometimes called the health/legal approach (Jones, Joscelyn, and McNair 
1979) .  
Indirect health countermeasures also exist. One such countermeasure 
is treatment of drug abuse and dependence problems in general; the 
treatment program may deal with substance abuse and highway safety. 
Many of those who are referred to treatment programs are referred by the 
legal system, and others are directed there by their employers. For 
example, federal agencies are required by regulation to implement drug and 
alcohol abuse programs for their employees, and all branches of the 
military report that they conduct education and treatment programs 
d i rec ted  in par t  a t  drug abuse, Another class of indirect health 
countermeasures parallels public information e f fo r t s ;  hea l th  c a r e  
professionals who dispense drugs are informed of the adverse effects of 
drugs on human performance, including driving performance,  and 
countermeasure efforts sometimes attempt to change prescription practices 
(Joscelyn et al. 1980). 
Public Information and Education Countermeasures 
In drugs and traffic safety,  public information and education 
countermeasures may be considered a part of health countermeasures in 
general, or as activity supporting other countermeasures. They include 
both classroom-oriented programs (educational programs) that impart drug- 
related information; and more informal information-dissemination efforts 
(public information programs). Education programs range from general 
courses such as those that deal with driving or public health and focus 
only tangentially on drug-impaired driving, to more specific areas such as 
drug and substance abuse and courses aimed at health professionals and 
highway safety specialists. Public information countermeasures include 
efforts by both government and private entities (such as pharmaceutical 
manufacturers' associations) and are generally aimed a t  increasing 
awareness about the impairing effects of drugs on driving ability. 
Generally, both the literature and contacts with operational agencies at 
the stiste and local level indicate little activity has occurred in the past to 
educate and inform the public about the effects of drugs on driving and on 
the magnitude of the drug and driving problem. The lack of activity is 
not surprising in light of the lack of knowledge about drugs and driving 
that could support countermeasure programs. Recently, we contacted 190 
state and local agencies to determine whether they had specific programs 
for education, public information, or referrals. Only three programs were 
identified, all in the area of driver education. No specific drug and 
driving programs were found in the areas of general health education, 
substance abuse education, professional medical education, or professional 
education for highway specialists (Joscelyn et al, 1980). 
Techn~~logical  Countermeasures 
Unlike alcohol and highway safety, where technology has played a major 
role in detecting and prosecuting offenders and a lesser role in preventing 
impaired driving, t ethnological countermeasures to drug-impaired driving 
are less developed. This remains the case despite marked advances in the 
state of the art in drug detection and quantitation. One primary reason 
why this is so is the lack of BAC-equivalents for drugs other than alcohol, 
combined with a widely held belief that chemical tests for drugs are still 
not worth the expense of time and funds. Other difficulties with present 
chemical test procedures is that blood is the only substance that can be 
analyzed for meaningful results, and testing equipment is nei ther  
conven~ient nor widely available. Efforts are under way to develop portable 
drug scireeners for roadside use in law enforcement. 
Systems Countermeasures 
The systems approach to a problem is a methodical combination of 
several countermeasure approaches. In alcohol and traff ic safety, the 
former Alcohol Safety Action Project (ASAP) applied the systems approach 
to the problem drinking driver and later to all drinking drivers. ASAP, 
which operated between 1969 and 1975, was a federally sponsored program 
that operated in selected jurisdictions throughout the United States. 
Individual projects were conducted a t  the local level and emphasized 
improved law enforcement, more efficient traffic court procedures, public 
information, and special efforts to counsel and assist drivers. No 
nationwide program comparable to ASAP has been conducted for drugs 
other than alcohol, and none are anticipated soon at either the federal or 
the state level. 
DIRECTIONS FOR FUTURE ACTIVITY 
Although present knowledge does not conclusively show that drugs other 
than alcohol and driving represent a priority highway safety problem, there 
exists enough evidence-including the impairing potential of many drugs, 
and the widespread use of drugs by the driving population-that points to 
the existence of such a problem. This is supported by anecdotal evidence 
from the field that a drug and driving problem has become more serious in 
recent years, 
So far, society's response to the perceived drug and driving problem is 
similar to its response to the alcohol and driving problem earlier in this 
century. Research is underway to better define the problem, and to 
support countermeasure development. The legal system-both criminal and 
adminis trative-is the means by which society applies countermeasures to 
manage the perceived risk created by drugs and driving, 
At the broadest level, future activity in drugs and highway safety 
should be directed at improving both the problem-definition process through 
improved research in drugs and highway safety, and the societal response 
to that problem through more effective countermeasures to drug-impaired 
driving. 
Improved Research in Drugs and Highway Safety 
Operating motor vehicles is a basic way of life in the United States. 
Traffic crashes are a significant cause of deaths and associated losses, 
especially among young adults; total crash losses exceed $ 3 5  billion per 
year [[National Safety Council 1980). That being the case, allocating 
efforts and funds to increase understanding of safe and deficient driving 
performance appears to be a wise use of resources. To better define the 
drug and driving problem, and to develop and implement more effective 
countermeasures, i t  is necessary to continue both experimental and 
epidem~iological research in this area. Much of the research to date has 
been fragmentary and poorly coordinated, and is subject to methodological 
criticisms. On a global level, these problems should be addressed as 
furtherb drug and driving research proceeds, Within the respective areas of 
epidemiology and experimentation, a series of specific, critical issues 
should be examined. 
Experimental Research. Past experimental research, with few 
exceptions, has been fragmentary, has lacked depth, and has uncertain 
meaning for practical concerns of traffic safety. Some substances have 
been studied many times with mixed results; findings for many others are 
almost nonexistent, If future research is to advance the s ta te  of 
knowledge about the effects of drugs on driving, severa l  c r i t i ca l  
considerations must be addressed. The first of these is realistically 
determining whether a specific drug presents a hazard to highway 
safety,, If an experiment is to be relevant to traffic safety efforts, it 
should ensure that characteristics of drug use (such as dosage, frequency of 
consumption, time of use, and circumstances of use) match those of the 
general population, and that research subjects match the user population. 
This has not been the case in much research to date, and the study results 
have, ass a result, had limited usefulness. 
The second consideration is better measurement of drug effects on 
driving-related performance. Not enough is known about the actual 
driving task, the performance skills and other factors that influence 
driving. Unless the factors that determine safe driving are known, it is 
quite difficult to measure impairment of safe driving performance. Thus 
basic research on the actual driving task is needed, and laboratory 
techniques should reproduce the driving task more exactly and completely. 
The third major considerat ion is developing standards for 
determining whether drug concentration has rendered a person 
incapable of driving safely. In alcohol-impaired driving prosecutions, 
BAC is the standard by which impairment is measured. For drugs other 
than alcohol, BAC-equivalents are theoretically possible but none have yet 
been established. For some drugs, they may never be established because 
of differences in the way people respond to drugs and variances in the 
amounts of drugs in subjects1 blood, Therefore, alternative approaches to 
measuring other drug impairment-for example, roadside behavioral tests- 
should be explored. 
Fourth,  fu tu re  experimental  research should deal  with what 
experimental designs most effectively assess the effects of drugs and 
combinations of drugs. Drug effects vary widely from drug to drug, and 
from user to user. Some therapeutic drugs, for example, enhance driving 
performance when they are  used to treat impairing medical conditions. 
More generally, drug effects vary with dose, frequency of use, physiological 
and psychological condition of the user, and the user's ability to 
compensate for their effects. With this in mind, designs of experimental 
studies should not only examine impaired performance per se, but also 
ffreal-worldtt factors that may mitigate the impairing effects of drugs. 
Finally, future research should ensure validation of laboratory and 
other experiments by intermethod comparison. Research to date has 
varied so widely from experiment to experiment that even studies 
purporting to measure the same behavior or the effects of the same drug 
have produced widely different results. 
Epidemiologic Research. The purpose of experimental research is to 
assess the potential traffic safety risk of drugs other than alcohol. 
Although experimental research can show that certain drugs, taken in 
sufficient quantities, can impair skills believed to be related to driving;, 
they cannot by themselves establish a causal link between drug use and an 
increased risk of traffic crashes. This is the function of epidemiologic 
research, Methodologies used in epidemiologic research have received more 
attention than those in experimental research. One shortcoming of past 
research on drugs and driving is the lack of comparisons between 
populations of crashed drivers and "at riskn or noncrashed drivers. 
Without such comparisons, no objective statement about the relative 
probability of having a drug-involved crash is possible. The importance of 
conducting at-risk studies cannot be stressed enough. Even so, substantial 
constraints exist on this type of research. It is still necessary to identify 
approaches that will result in acceptable levels of cooperation by drivers 
stopped a t  the roadside and asked for data or specimens; pilot studies 
addressed to the cooperation issue should precede large-scale surveys of 
drug use in  the driving population. Another problem found in roadside 
surveys of drug use that does not exist with respect to alcohol is that only 
blood specimens will yield acceptable results, which rules out the use of 
convenient, portable, or nonintrusive testing procedures. The alcohol 
literature contains a great deal of roadside survey results pertaining to 
alcohol. use by the at-risk population. These provide the basis for drug and 
driving research using roadside surveys. 
Future epidemiologic research should concentrate on a broad range of 
drugs a t  therapeutic or effective concentrations. Much prior research 
has been based on drug dcsages that differ greatly from those generally 
taken by the user population. For therapeutic drugs, the therapeutic 
concentration or normally prescribed dosage is most typically found in the 
population. For nontherapeutic drugs, the equivalent measure is an 
''effective concentration," that which will produce an unacceptable 
impairment of safe driving ability. At the very least, the range of drugs 
should include those that are of greatest interest to traffic safety a t  
therapeutic and effective levels. When necessary, state efforts should be 
supported with highway funds to increase the analytic capability of 
agencies involved in this form of research. 
A variety of agencies now conduct epidemiologic research and refer 
specimens to several laboratories that vary in their quality and capability 
for detection and quantitation. The comparability of analytical results 
obtained from different laboratories remains uncertain at best, especially 
when quantitative measurements are compared. Until quality control and 
proficiency testing establish the validity of comparing data from separate 
sources, a single, qualified laboratory should be used for projects in which 
findings must be consistent with one another for later comparison and 
interpretation. 
Finally, the use of other sources of information on patterns of drug 
use and driving should continue. National, state, and local questionnaire 
studies concerned with drug use should contain questions related to traffic 
safety, especially respondentsf drug and driving experience. This kind of 
data is admittedly subject to biases and cannot distinguish among specific 
drugs, but in spite of that, some assessment of pertinent attitudes and 
behavior in different driving-age populations that use drugs-both licit and 
illicit-would assist in estimating the scope and magnitude of the drug and 
driving problem. 
More Effective Countermeasures to Drug-Impaired Driving 
Countermeasure approaches to drugs and driving have paralleled those 
used to combat alcohol-impaired driving. The chief means of social 
control directed against a drug-impaired driver are legal; in particular, 
punishment and the threat of punishment are used to discourage persons 
from driving while impaired. Other countermeasures are used as well, but 
the level of activity, both on an absolute basis and in comparison with the 
level of activity devoted to alcohol-impaired driving, is comparatively low. 
Legal Countermeasures. Existing s tate  laws intended to prevent 
driving while under the influence of marijuana or other drugs are in 
disarray. A drug-impaired driver could escape prosecution because a 
chemical test cannot be requested; by choosing a test such as breath that 
will not reveal the drug being used; by using a substance that does not fit 
a narrowly defined category of ffdrugs"; or by using drugs and alcohol in 
combination. At least one of these loopholes exists in the laws of all but 
twelve states. Law revision is needed if legal countermeasures to drug- 
impaired driving are to be relied on. Our companion volume, Alcohol, 
Drugs, and Traffic Law (Joscelyn and Ruschmann 1981), contains specific 
recommendations. 
Thcr need for more effective laws has been recognized by the drafters 
of the Uniform Vehicle Code. Model legislation has been drafted that 
addresses each of the major shortcomings of existing state law. States 
should be encouraged to adopt the substantial provisions of the UVC 
related to alcohol, other drugs, and driving. The experience of the states 
that (40 adopt new laws and of those states that now have similar 
provisions in effect should be evaluated. Problems i n  enforcement, 
prosecution, adjudication, and sanctioning should be identified. The 
effectiveness of legislation in reducing such problems should be assessed. 
The N$ational Committee on Uniform Traffic Laws and Ordinances should 
be supported to assist states in developing legislation and, if necessary, to 
revise the Uniform Vehicle Code to address new problems. 
Public Information and Education Countermeasures. While the 
existence of a serious drug and driving problem has not yet been confirmed 
by reslearch, there is sufficient evidence of a problem to warrant some 
effort to promote public awareness. Large-scale public information and 
education campaigns and o ther  special  programs requiring heavy 
expenditures are not appropriate because of the lack of a knowledge base 
to support such efforts. On the other hand, limited use of existing 
programs, such as the National Highway Traffic Safety Administration's 
"402 plrogramff of assistance to state and local jurisdictions, is indicated, 
Inform~~tion and education countermeasures directed at drugs and driving 
should take the form of: 
D driver education, 
o general health education, 
o drug abuse and substance abuse education, 
cs professional medical education, 
professional education for highway safety specialists, and 
public information and education 'fcampaignsl' for both the 
general public and special audiences, such as pharmacists. 
Knowledge about drugs that have the potential to impair driving should 
be shared with those who use them and with those who have 
responsibilities for highway safety management. What is known can be 
shared by including drug and driving information elements i n  existing 
education and public information programs that address both drug and 
highway safety issues. 
A major shortcoming of existing information and education programs 
dealing with drugs and driving is their fragmented nature and the lack of a 
comprehensive approach to the problem. Most present problems deal with 
drugs and driving peripherally as part of some other topic, such as drug 
abuse or alcohol and traffic safety. Mechanisms for developing a more 
integrated approach dealing with all aspects of the drug and driving 
problem need to be expressed. 
No program of public information and education can succeed without 
effective materials. To develop such materials, the first  step is to 
conduct an in-depth analysis of present programs, what they contain, and 
how their message is disseminated. The results of this analysis should be 
collated, indexed, and made available to researchers and practitioners in 
the field, 
The information area also includes the function of linking researchers, 
policymakers, and practitioners in the fields of traffic safety and drug 
abuse. The drug and driving field, as a whole, includes several areas of 
research, each of which involves many disciplines. At the same time, so- 
called action programs to deal with the drug and driving problem have 
been initiated at  state and local levels. With both increasing interest and 
activity in this area, the need to integrate and transfer information 
relevant to drugs and highway safety has arisen, Specifically, a central 
clearinghouse for information on drugs and driving is needed, Such a 
clearinghouse would: 
Maintain and update collections of literature and other 
materials pertaining to all topic areas including research, 
methodology, legislation, and action programs; 
0 Prepare bibliographies that provide ready reference to 
sources of information; and 
Provide, upon request, information that can be used by 
researchers and practitioners alike. 
In addition to collecting and disseminating research reports and other 
information on drugs and driving, the clearinghouse could collect state and 
local data on the detection and measurement of drugs in drivers, integrate 
findings from contributing agencies, and analyze the continuous flow of 
information from the field. This basic function of such an information 
clearinghouse would be to link research to define the problem and action 
programs to deal with the problem. The problem of drugs and highway 
safety is one in which a clearinghouse, to which state and local officials 
can turn to  for information and other  support, is needed. The 
clearinghouse could not only provide needed information but also lead to 
the establishing of ltnetworksn among state and local agencies that face 
similar problems and are engaged in similar activity. 
What is known also needs to be considered as decisions are made to 
allow additional substances to enter the marketplace, The introduction of 
new drugs, similar to those shown to have the potential to impair driving, 
and which are identified as playing causative roles in traffic crashes, 
should occur only after acquiring evidence that allows a complete weighing 
of the risks and benefits of the drug. The risk potential of a new drug to 
highway safety should be included in this risk-benefit analysis. This 
responsibility falls within the purview of the Department of Health and 
Human Services and its agencies. 
Technological Countermeasures. In drugs and traffic safety, 
development of countermeasure approaches has paralleled that of alcohol 
crash countermeasures. One specific standard of drug impairment is 
sought, especially by those in the legal system through which most control 
forces are directed at  the drug and driving problem. Develo~ment of a 
BAC-equivalent for other drugs dictates a heavy emphasis on technological 
countermeasures, especially devices that can detect and quantitate drugs in 
body fluid specimens. Unlike alcohol, however, other drugs are more 
complex, more varied, more likely to produce a wider variety of effects on 
their users, and more apt to behave differently from one another when 
metabolized in the human body. That being so, developing BAC- 
equivalents, even for a small number of drugs, will require much larger- 
scale experimental research on the relationship between drug concentrations 
and effects on driving performance than occurs today. It will also require 
a great increase in personnel, equipment, and facilities for conducting drug 
analyses. Even if such resources are available and affordable, the 
development process is likely to take years. Once equivalent measures are 
developed, they must gain legal acceptance--a lone; process that will 
require, a t  a minimum, the legal changes outlined earlier as well as expert 
testimony in court to establish the scientific validity and fairness of 
objective drug-impairment measures. 
The anticipated outlay of resources to develop BAC-equivalents is so 
great that it may not be justified in light of the likely benefits to be 
gained. Also to be considered are practical and political obstacles; for 
example, citizens may recent new laws permitting more intrusive testing 
procedures, or higher taxes to support testing and research. While 
abandonment of the search for BAC-equivalents is not recommended, 
examination of the premises underlying this search should take place. 
Specificallv, at this point in the examination of the drug and driving 
problem, some basic policy analyses should be performed. Whether it is 
wise to continue following the alcohol experience in dealing with drugs and 
driving should be carefully examined. In particular, the feasibility of 
developing and relying on the BAC-equivalent concept should be evaluated. 
The feasibility of using means other than chemical analysis to prove guilt 
of drug-impaired driving should be examined. More generally,  an 
examination should include a detailed review of whether it is feasible to 
continue relying on the criminal justice system as the major social control 
systerri for drug-impaired driving. Alternative control measures that rely 
on administrative approaches using nonpenal sanctions should also be 
considered. 
SUMMARY AND CONCLUSIONS 
Research is underway to assess the magnitude of the problem created 
by druig use by the driving population. Experimental research seeks to 
define the relationship between drug concentrations in the body and driver 
impairment. Epidemiologic research seeks to identify the actual risk of 
various drugs to highway safety. Countermeasures that have been used to 
deal with alcohol--including legal,  heal th ,  educat ion,  and public 
inforrriation--are under development and limited implementation. In 
particu~lar, the establishment of a BAC-equivalent for drugs other than 
alcohol. is sought but may not be feasible. 
With the exception of alcohol, present knowledge does not establish any 
drug as a priority highway safety concern. Research has established that 
many drugs have the potential to impair driving behavior and that these 
drugs are used by people who drive. Research findings and reports of 
operational agencies document crashes that involve drivers who have used 
drugs. Drivers arrested for impaired driving are found to have used drugs- 
-alone and frequently in combination with alcohol or other drugs. The 
frequency with which drug-impaired drivers drive and are involved in 
crashes i s  not known. The frequency of arrests for drug-impaired driving 
is m uoh less than that for alcohol-impaired driving. Preliminary data 
suggest that about one hundred arrests are made for alcohol-impaired 
driving for every one arrest for drug-impaired driving. Estimates for crash 
involvement cannot be made on the basis of existing data. 
Present knowledge supports the need for further inquiry to establish the 
nature and magnitude of the drug and driving problem. While objective 
data do not exist to support statements that the drug and driving problem 
is increasing, it is the perception of operational personnel-including police, 
prosecutors, health specialists, drug abuse experts, and hiqhway safety 
specialists-that the problem has increased in recent years. These views 
should not be ignored. They establish the need for careful inquiry to 
develop the necessary objective data to define the problem. Of greatest 
need are epidemiologic data on drug use among drivers representative of 
both crash- and non-crash-involved populations. 
Present knowledge also indicates that examination of the drug and 
driving problem should consider a broader range of drugs than controlled 
substances and marijuana, Other psychoactive drugs, including 
antidepressants, major tranquilizers, outpatient anesthetics, and medications 
available over the counter for self-treatment are also of interest, 
Knowledge about the patterns of drug use suggests that polydrug use 
should be a major concern. In particular, the combined use of alcohol and 
other drugs in conjunction with driving is a priority interest, Such use 
may produce impairment  de l ibera te ly  when drugs are abused or 
inadvertently when medications are  used in combination with social 
drinking. 
The state of knowledge suggests directions for the future. Efforts need 
to be undertaken to define the problem. Nevertheless, some actions can 
be taken now on the basis of existing knowledge. There are major policy 
issues that should be examined to focus future activity. Improvements in 
both epidemiological and experimental research are indicated. Experiments 
should be carried out under conditions that more realistically account for 
drug use patterns in society as well as what skills are required to drive 
safely. Epidemiological research, to be meaningful, must compare crashed 
(both killed and living) and noncrashed (both arrested and Ifat riskff) driver 
populations, Research studies should be designed and carried out in a 
more consistent manner to ensure comparability across studies. The form 
of countermeasures to the drug and driving problem will be shaped not 
only by the problem definition resulting from research, but also by a 
societal determination whether the legal system should remain the primary 
risk-management system directed at the drug-crash risk. Specifically, so 
much time, money, and personnel may be required to establish reliable, 
objective standards of drug impairment that are legally acceptable that the 
legal approach may be as costly as the problem, or at least more costly 
than other, effective strategies. For example, a BAC equivalent for many 
drugs of interest is not presently available and may never be available for 
some (drugs. If reliance on the legal system continues, then present laws 
that often contain loopholes allowing drug and driving suspects to escape 
proseciution must be amended. Information regarding drugs and driving is 
not plentiful when compared to the body of information related to alcohol 
and driving. What information exists is often not effectively presented to 
the public, and is not handled in a manner that allows for exchange among 
researchers, practitioners, and policymakers, 
In sum, available knowledge indicates that a potentially serious drug and 
driving may exist, but its magnitude has not been established bv reliable 
scientific evidence. The problem appears serious enough to trigger formal 
responses by society, chiefly the passage and enforcement of laws to 
prevent it, However, a large-scale commitment of additional resources to 
attack the perceived drug and highway safety problem should not be made 
until further research more clearly defines its magnitude. 
WHAT CAN BE DONE? 
Although the magnitude of the drug-crash problem has not been 
determined with precision, enough is known now to support formal action 
by society. A number of actions can-and should-be taken at the state 
and loc!al level to reduce the drug crash risk. 
To date society has relied primarily on the legal system to control 
social risks such as traffic crashes and the losses they produce. Other 
countermeasure approaches, including health and public information 
strategies, are available and they should be used as well. 
Specific actions related to law generation and enforcement that can 
be taken by units of state and local government include: 
o Revision of state laws to eliminate nloopholesn that impede 
prosecution of drug-impaired drivers, Provisions that restrict the 
ridmission of chemical test results into evidence, allow a driver to 
ohoose a test other than blood, or exclude licit drugs from the 
sicope of their coverage unnecessarily restrict the efforts of law 
enforcement agencies to deal with impaired driving, 
Our companion volume, Alcohol, Drugs, and Traffic Law (Joscelyn 
and Ruschmann 1981) ,  contains specific recommendations for law 
revision and model legislation taken from the Uniform Vehicle Code. 
Reliance on qualitative evidence to establish guilt of drug- 
impaired driving. Even though no BAC-equivalent exists for any 
substance other than alcohol, the absence of quantitative standards 
for other drug impairment does not excuse failing to diligently 
Prosecute cases of driving while under the influence of drugs. 
Before the BAC concept was developed and accepted, drunk driving 
was proved by qualitative evidence such as driving; errors, poor 
performance of coordination tests, and the odor of alcohol. Similar 
evidence should be relied on to prove impairment by other drugs. 
Prosecuting attorneys and police officers shouid be given reliable 
information regarding proof by behavioral evidence of drug-impaired 
driving and should receive appropriate training. 
In the past many legal countermeasures, especially those relating to 
alcohol-impaired driving, have been supported by information and education 
flcampaignsff intended to increase public awareness of and support for 
countermeasure activity. In addition, information and education efforts 
also have been directed towards specialized audiences who are in a position 
to impart essential information to individual drivers about traffic safety. 
Specific actions relating to information and education include: 
Identifying more clearly the target audiences for public 
information and education programs. In particular, two 
subpopulations with contrasting drug usage patterns should be priority 
targets of information and education efforts. The first of these 
consists of drug-sensitive users, especially elderly persons, who 
regularly consume one or more therapeutic drugs and whose driving 
ability is impaired as a result. Many of these users are not aware 
of whether, and to what degree, their driving skills are affected. 
They need specific information that addresses that topic. 
The second subpopulation consists of drug experimenters, chiefly 
young adults who abuse licit drugs, use illicit drugs, and use alcohol 
and other drugs in combination. Most of the drug use within this 
group is recreational. Their information needs include what 
impairing effects are likely to follow the use of drugs, and what 
actions society will take if drug-impaired driving occurs. 
e Directing information and education programs at those 
within the health-care system. Most licit drugs are controlled 
and therefore legally available only through the health-care system. 
These therapeutic substances are prescribed by physicians and are 
dispensed by pharmacists. Both groups1 distribution patterns may 
contribute to the prevalence of drug-impaired driving by licit drug 
users. Since most of this contribution is inadvertent, information 
programs informing physicians and pharmacists of the impairing 
potent ial  of therapeut ic  drugs likely will result in changed 
distribution policies. The aid of state and local health departments, 
s t a t e  regulatory agencies  such as boards of pharmacy, and 
professional societies should be enlisted in this effort. 
Increasing attention has been paid to health-oriented countermeasures 
that treat substance abuse problems underlying such law violations as 
impaired driving. With respect to alcohol-impaired driving, the treatment 
functiolns of the health-care system have been coordinated with the 
sanctiolning function of the legal system, and a health/legal approach has 
been a.dopted toward the drinking driver. The same approach can be 
directed at the driver who misuses other drugs. 
Specific actions relating to hea l th  and hea l th l lega l  s t r a t e g i e s  
include: 
e Using law-enforcement  agencies  a s  nease  f indersn f o r  
persons who abuse or misuse drugs o the r  than alcohol. The 
police currently perform this function by "finding" Dersons who abuse 
alcohol in the course of their enforcement of drunk driving laws. 
'The adjudication and sanctioning process is often used as a means of 
channeling alcohol offenders into appropriate treatment programs. 
Probation s t a t u s  or re ten t ion  of driving privileges is often 
conditioned on seeking treatment for underlying alcohol problems. 
Many drug-impaired drivers are not recreational drug users but 
rather users of impairing therapeutic drugs. Often these drivers are 
~rlot aware of the degree to which they are impaired or of the 
'traffic crash risk they present while driving. That these offenders 
;are not drug abusers or recreational drug users is a fact that should 
be known by treatment personnel who handle referrals from the 
courts. 
ID Supplementing l ega l  sanct ions with t r e a t m e n t  programs 
irather than subst i tut ing t r e a t m e n t  for  sanctions.  Treating 
offenders with drug problems is sound policy from both a practical 
t~nd a humane standpoint. However, prior study of health/legal 
approaches to drunk drivers indicates that merely treating an 
i mpaired-driving of fender does not significantly improve that person's 
driving (e,g., Nichols et al. 1978). The only countermeasure that has 
been proven effective is license revocation or suspension. Drug 
abusers and recreational users who operate vehicles while impaired 
should receive driving sanctions whether or not they are referred to 
treatment. 
On the other hand, the therapeutic user who is not aware of his 
or her impairment, or of the hazard that impairment creates, has 
not engaged in the type of conduct that licensing action attempts to 
deter, Treatment and information about drug effects are more 
appropriate responses to impaired driving by this type of user. 
All of the countermeasures we described can be implemented in the 
immediate future by units of s ta te  and local government.  These 
countermeasures do not necessarily represent the most effective strategies 
possible. Research that will lead to more effective countermeasure 
approaches should continue; however, changes in the direction of that 
research are indicated. 
Specific actions related to research include: 
C o n d u c t i n g  e p i d e m i o l o g i c  s t u d i e s  t o  d e t e r m i n e  t h e  
preva lence  o f  drug impairment in the crashed and arrested 
driving populations. Epidemiological research to date has consisted 
of a few studies of drug prevalence, chiefly among fatally injured 
drivers. Most of these studies have exhibited methodological flaws, 
and comparisons among studies and to noncrashed populations are not 
possible. Research is needed to determine more clearly how 
prevalent drugs are among the crashed and at-risk populations, and 
what drugs and classes of drivers are most frequently represented. 
A word of caution must be added, however. To achieve usable 
epidemiological data, rigorously designed and controlled studies must 
be carried out. These are costly and time-consuming, While 
isolated or small-scale studies with few controls appear to save time 
and money in the short run, their contribution to the state of 
knowledge in drugs and driving will be minimal. 
Allowing experimental research t o  proceed a t  the national 
rather than the s ta te  and local level.  Experimental research into 
d r i v i n g  behav io r  is even more complex and costly than 
epidemiological research. The time and expense associated with 
such studies is probably too great for state and local governments to 
conduct or finance. Nationwide studies with rigorous controls appear 
to be the only feasible approach for obtaining usable experimental 
data. 
In some widely reported studies, crude closed-course driving tests 
have been conducted to determine drug effects on driving ability. 
Reliance on these studies is misplaced because these tests do not 
produce accurate measures of driving performance, in large part 
because the tes t ing  s i tua t ion  induces ar t i f ical ly enhanced 
performance, 
In sum, not enough is known about the drug and driving problem to 
justify an unequivocal conclusion that it should take priority in traffic- 
safety programs. However, enough is known about it to justify societal 
action. Near-term strategies involving legal, health, and public information 
countelmeasures are available and should be implemented at the state and 
local level. Research to further define the drug and driving problem and 
supporl: countermeasure development should continue, especially a t  the 
nation611 level. While the problem is being more precisely defined, state 
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